Eating Disorders and GLP-1 RAs

Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications
originally developed to treat type 2 diabetes. GLP-1 RAs are now being used as an approved or off-label treatment for weight loss and have been trialled as a treatment for some eating disorders such as binge eating disorder (BED).

There is limited research available to help researchers, clinicians and patients/consumers to understand 
the relationships between GLP-1 RAs and eating disorders. However, it is thought that GLP-1 RAs may 
negatively impact eating disorder symptomology and treatment in a number of ways.

This factsheet provides information about GLP-1 RAs as well as their possible interaction with eating disorders including physical and psychological impacts. Practice points are provided for clinicians.


« Back to Browse Resources

See also

Stepped System of Care - Vietnamese

National Eating Disorders Collaboration (NEDC) đã tích hợp hai thập kỷ của ngành và kinh nghiệm sống đồng thuận cũng như sự phát triển dịch vụ thành một mô hình của hệ thống chăm sóc từng bước cho chứng rối loạn ăn uống (Hình 1).

Read more

Summary paper - NDIS engagement for people with eating disorders

The National Disability Insurance Scheme (NDIS) has been operational in Australia for ten years.

Read more

NEDC Fact Sheet - Cognitive Behavioural Therapy Guided Self Help (CBT-GSH)

This resource is for GPs and health professionals who are seeking a better understanding of Cognitive Behavioural Therapy Guided Self Help (CBT-GSH) in eating disorders, and their role in using this as a treatment in some eating disorder presentations.

Read more

Stepped System of Care - Chinese (Simplified)

National Eating Disorders Collaboration (NEDC) 将二十年的各部门及患者亲身体验共识与服务发展整合为阶梯式饮食 
失调护理系统模型（如图1所示）。该模型的目的是描述在有效的饮食失调护理系统中应该具备的组成部分。患有或可能患
有饮食失调的人士及其家人/支持者和社区可能需要在疾病（或可能患病）和康复过程中，以不同的强度或频率获得一系列
不同的服务。这个护理连续过程的进展并非直线单向的，一个人可能需要针对其不断复发的症状接受治疗和支援服务，而
这些服务来自阶梯式护理系统的不同级别和不同的服务提供机构。

Read more